Assays News: Breaking Assays News, Comments and Articles. - Page: 2

Roche's rapid mycoplasma detection test MycoTOOL receives acceptance from Canadian authorities for release testing of biopharmaceutical Roche product

Today Roche announced that the Canadian Health Authority has accepted the use of its PCR based mycoplasma detection test MycoTOOL for release testing of one of Roche's biological products. The test can replace conventional and time-consuming myc...

Roche’s Rapid Mycoplasma Detection Test MycoTOOL Receives Acceptance from Canadian ...

PCR test reduces time for mycoplasma detection from one month to one day Penzberg, Germany, 13 June 2013 / B3C newswire / - Today Roche announced that the Canadian Health Authority has accepted the use of its PCR based mycoplasma detection test MycoTOOL for release testing of one of Roche’s biological products. The test can replace conventional and time-consuming mycoplasma detection assays...

Amarantus Engages BD Biosciences for Development of Alzheimer’s Diagnostic

Amarantus BioScience Holdings, Inc. (OTCQB: AMBS), a biotechnology company discovering and developing treatments and diagnostics for diseases associated with neurodegeneration and apoptosis, today announced it has signed a laboratory services agreement with BD Biosciences, a segment of BD (Becton, Dickinson and Company) , a leading global medical technolog...

New fluorescent protein from eel improves key clinical assay

Unagi, the sea-going Japanese freshwater eel, harbors a fluorescent protein that could serve as the basis for a new clinical test for bilirubin, a critical indicator of human liver function, hemolysis, and jaundice, according to researchers. The disc...

UCB to collaborate with CRELUX and 4SC Discovery in neurology drug discovery

UCB, CRELUX GmbH and 4SC Discovery GmbH have established a drug discovery collaboration to identify and validate novel small-molecule compounds for the treatment of neurological disorders. The collaboration will be part of UCB’s strategy of buildin...

Abcodia and Austrian Institute of Technology collaborate on biomarkers for lung and colorectal cancer

Abcodia, a biomarker validation company with a focus on cancer screening, has established a collaboration with the AIT Austrian Institute of Technology which will focus on the validation of biomarkers for the early detection of lung and colorectal ca...

JAMA Pediatrics Study Highlights Cancer Risk Associated with CT Scans

CASTLE ROCK, Colo., June 13, 2013 /PRNewswire/ -- Venaxis, Inc. (Nasdaq: APPY), an in vitro diagnostic company focused on obtaining FDA clearance and commercializing its CE Marked APPY1 Test, a rapid, protein biomarker-based assay for identifying patients at low risk for appendicitis, today announced its support of key findings from a large retrospective study that was published ear...

Silicon Valley Biosystems' Computational Diagnostics Laboratory Receives CLIA Certification

FOSTER CITY, Calif., June 13, 2013 /PRNewswire/ -- Silicon Valley Biosystems (SV Bio) today announced that it has received Clinical Laboratory Improvement Amendment (CLIA) certification from the California Department of Public Health for its in silico diagnostics laboratory. Obtaining CLIA certification demonstrates that SV Bio's computational laboratory, which performs next-generation sequen...

RiboMed and Austrian Institute of Technology Partner on Epigenetic Tests for Early Lung Cancer Detection, Sub-typing and Drug Response

RiboMed Biotechnologies, Inc. (http://www.ribomed.com), a company that develops epigenetic-based tests that provide improved cancer diagnosis and allow drug therapy to be personalized for the benefit of cancer patients, today announced that it has partnered with researchers at the Austrian Institute of Technology (AIT, Vienna) to commercialize their clinically validated lung cancer DNA methylation...

Personalizing cystic fibrosis in vitro

A team at University Medical Center Utrecht has developed a rapid and quantitative in vitro intestinal cell-based assay for function of cystic fibrosis transmembrane conductance regulator that could help identify …

AAPS PharmSciTech: Development and Validation of a HPLC Method for Dissolution and Stability Assay of Liquid-Filled Cyclosporine Capsule Drug Products

Type: Original PaperTo assay the dissolution samples of a drug product from several sources, a simple but broadly applicable analytical method is always desired. For the liquid-filled cyclosporine capsules, while analyzing the dissolution samples, th...

A Novel Translational Assay of Response Inhibition and Impulsivity: Effects of Prefrontal Cortex Lesions, Drugs Used in ADHD, and Serotonin 2C Receptor Antagonism

Derma Sciences Reports Results from DSC127 Pharmacokinetic Study

Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, announces that all data from the pharmacokinetic (PK) study with 0.03% DSC127 gel has been collected and analyzed. The open-label, single center, Phase 1 PK study enrolled 21 diabetic subjects with at least one chronic non-healing Wagner Grade 1...

New Advances and Opportunities in Managing Pain: Translational Animal Models, New Webinar Hosted by Xtalks

Xtalks presents an exciting live webinar on Wednesday June 19, 2013 at 11am EDT on various animal models of pain used to explore the efficacy of novel new drug candidates. Toronto, Canada (PRWEB) June 12, 2013 Animal models provide pivotal systems for the preclinical study of pain. Recently, there has been increased attention and discussion focused on the lack of translation of potential pain the...

Proteome unveils largest contract to date; shares drop

Shares in biotech company Proteome Sciences (LON:PRM) dropped more than 5% on Wednesday despite announcing a $2.1million contract - its largest to date. The firm unveiled a technology agreement with Thermo Fisher Scientific, valued at $2.1million by...

ARUP Laboratories Wins Legacy Award Presented by Premier Healthcare Alliance

SALT LAKE CITY, June 12, 2013 /PRNewswire/ -- ARUP Laboratories announced a victory today as a recipient of the first-ever Legacy Award by the Premier healthcare alliance. (Logo: http://photos.prnewswire.com/prnh/20110915/SF69370LOGO) The Utah-based laboratory is one of 18 suppliers to receive the Legacy Award this year. Winners are recognized for their outstanding support for alliance members...

Pharmaceutical Research: The Potential Efficacy of R8-Modified Paclitaxel-Loaded Liposomes on Pulmonary Arterial Hypertension

Type: Original PaperPurposeIn this paper, a novel liposomal formulation of paclitaxel modified with octaarginine (R8) was fabricated and the therapeutic efficacy of it on pulmonary arterial hypertension was evaluated.MethodsOctaarginine-modified stea...

Pharmaceutical Research: BSA-PLGA-Based Core-Shell Nanoparticles as Carrier System for Water-Soluble Drugs

Type: Original PaperPurposePreparation, optimization and in vitro evaluation of core-shell nanoparticles comprising of a hydrophilic core of BSA surrounded by a hydrophobic shell of PLGA for loading water-soluble drugs.MethodsA double emulsion method...

Endeavor Power Corporation Issues Corrections on two of its earlier Press Releases dated January 9, 2013 and March 8, 2013

CAMBRIDGE, Mass., June 11, 2013 /PRNewswire/ -- Endeavor Power Corporation ("Endeavor Power" or the "Company") (OTCQB: EDVP) provides corrections to two separate press releases issued by the Company on January 9, 2013, with the headline "Endeavor Power Corporation Outlines Its New Target market, Its Size and Projected Growth," and March 8, 2013, with the headline "Endeavor Power Corporation I...

Tetracore® Inc. Announces the Successful Completion of a Comprehensive Laboratory Validation of the Tetracore BioThreat Alert® Lateral Flow Assay for the Rapid Detection of Ricin by the United States Department of Homeland Security.

ROCKVILLE, Md., June 11, 2013 /PRNewswire-USNewswire/ -- Tetracore Inc., a biotechnology company, announces the successful completion of an extensive study of its Ricin BioThreat Alert  Lateral Flow Assay (LFA) and BioThreat Alert LFA Reader by the Department of Homeland Security (DHS). Tetracore Ricin BioThreat Alert LFA is designed to deliver quick and accurate results in the field or...

Critical Diagnostics' Biomarker ST2 Included in the 2013 ACC/AHA Guidelines for the Management of Heart Failure

Critical Diagnostics announced today that the American College of Cardiology Foundation/American Heart Association Task Force jointly released its expanded clinical practice guideline for the management of patients with heart failure and has identified ST2 “not only predictive of hospitalization and death in patients with HF [heart failure] but also addi...

3M Food Safety Leverages Petrifilm Technology for Pathogen Detection

3M Food Safety announces the launch of the 3M™ Petrifilm™ Salmonella Express System, a new pathogen detection technology that builds upon a solid platform of pathogen detection solutions. Immediately available worldwide, this system is focused on Salmonella, which comprises nearly half of all pathogen testing. Though not previously available as a patho...

GE Healthcare launches new software to expand Biacore T200’s capabilities for highly sensitive, focused screening

June 11th 2013: Biacore™* T200 Software v.2.0 enhances the capabilities of Biacore T200, offering researchers a flexible and powerful tool for efficient processing of molecular interaction data. Together, they facilitate label-free screening of low molecular weight compounds and low abundance proteins, giving detailed binding profiles on molecule-drug candidate mechanisms of action that...

Natural Molecular Testing Corporation Launches an Expanded Personalized Medicine Panel Built on Luminex Corporation's xMAP Technology

SEATTLE, June 11, 2013 /PRNewswire/ -- Natural Molecular Testing Corporation (Natural Molecular, NMTC), a privately-owned company providing groundbreaking clinical diagnostic molecular testing and services in the medical genomics field, announced today the launch of their laboratory developed comprehensive Personalized Medicine Panel. This cardiac panel, commercialized by Natural Molecular, i...

US EPA and NanoLogix to Extend Agreement to 2015

NanoLogix Provides Operations Update NanoLogix Inc. (NNLX), an innovator in the accelerated detection, identification and antibiotic sensitivity determination of live bacteria, announces that the US Environmental Protection Agency and NanoLogix have agreed to extend their existing Cooperative Research and Development Agreement (CRADA) for two years, wi...